Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102. [electronic resource]
Producer: 20200428Description: 2198-2204 p. digitalISSN:- 2241-6293
- Aged
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Combinations
- Female
- Humans
- Male
- Middle Aged
- Muscle, Skeletal -- drug effects
- Neoplasm Metastasis
- Phenylurea Compounds -- administration & dosage
- Prognosis
- Pyridines -- administration & dosage
- Pyrrolidines -- administration & dosage
- Sarcopenia -- chemically induced
- Thymine
- Trifluridine -- administration & dosage
- Uracil -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.